AGA makes its first investment through new GI innovation fund

AGA has announced that the association’s new venture capital fund, GI Opportunity Fund 1, completed its first investment, rounding out the Series A financing of Virgo Surgical Video Solutions (“Virgo”) of Carlsbad, Calif.

Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.

AGA has announced that the association’s new venture capital fund, GI Opportunity Fund 1, completed its first investment, rounding out the Series A financing of Virgo Surgical Video Solutions (“Virgo”) of Carlsbad, Calif.

Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.

AGA has announced that the association’s new venture capital fund, GI Opportunity Fund 1, completed its first investment, rounding out the Series A financing of Virgo Surgical Video Solutions (“Virgo”) of Carlsbad, Calif.

Virgo provides gastroenterologists, clinical trial sponsors, and trial site investigators with artificial intelligence–fueled, always-on endoscopic procedure recording and patient recruitment tools for clinical trials in gastroenterology, starting with inflammatory bowel disease clinical trials.